desipramine has been researched along with atomoxetine hydrochloride in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gackenheimer, SL; Gehlert, DR; Schober, DA | 1 |
| Gackenheimer, SL; Gehlert, DR; Robertson, DW | 1 |
| Biederman, J; Faraone, SV; Spencer, T; Wilens, TE | 1 |
| Daley, KC | 1 |
| Wee, S; Woolverton, WL | 1 |
| Bergman, J; Gasior, M; Kallman, MJ; Paronis, CA | 1 |
| Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A | 1 |
| Hamrin, V; Rains, A; Scahill, L | 1 |
| Greenfield, B; Slatkoff, J | 1 |
| Allen, AJ; Faries, DE; Jasinski, DR; Moore, RJ; Schuh, LM | 1 |
| Ching, B; Fleck, BA; Gao, Y; Gogas, K; Hudson, S; Pontillo, J; Wade, WS; Wu, D | 1 |
| Jentsch, JD; Lang, A; Rivera, RJ; Seu, E | 1 |
| Bizot, JC; David, S; Trovero, F | 1 |
| García-Bueno, B; Hinojosa, AE; Leza, JC; Madrigal, JL | 1 |
| Barygin, OI; Belinskaya, DA; Nagaeva, EI; Shestakova, NN; Tikhonov, DB; Vanchakova, NP | 1 |
| Osland, ST; Pringsheim, T; Steeves, TD | 1 |
| Chierrito, D; Fernandez-Llimos, F; Sanches, ACC; Tonin, FS; Villas-Boas, CB | 1 |
5 review(s) available for desipramine and atomoxetine hydrochloride
| Article | Year |
|---|---|
Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Comorbidity; Desipramine; Humans; Mental Disorders; Methylphenidate; Propylamines; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Syndrome | 1998 |
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Guanfacine; Humans; Imipramine; Nortriptyline; Propylamines | 2005 |
Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Desipramine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic | 2006 |
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Desipramine; Dextroamphetamine; Female; Guanfacine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Selegiline; Tic Disorders | 2018 |
Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review.
Topics: Adolescent; Adult; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Child; Comorbidity; Desipramine; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
1 trial(s) available for desipramine and atomoxetine hydrochloride
| Article | Year |
|---|---|
Abuse liability assessment of atomoxetine in a drug-abusing population.
Topics: Adrenergic Uptake Inhibitors; Adult; Arousal; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cross-Over Studies; Desipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methylphenidate; Middle Aged; Pain Measurement; Phentermine; Propylamines; Risk; Substance-Related Disorders | 2008 |
12 other study(ies) available for desipramine and atomoxetine hydrochloride
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of (R)-[3H]tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain.
Topics: Animals; Atomoxetine Hydrochloride; Autoradiography; Binding Sites; Brain; Citalopram; Desipramine; Fluoxetine; Male; Norepinephrine; Propylamines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Tritium | 1995 |
Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites.
Topics: Animals; Atomoxetine Hydrochloride; Binding Sites; Desipramine; Fluoxetine; Kinetics; Ligands; Male; Nerve Tissue Proteins; Norepinephrine; Piperazines; Propylamines; Prosencephalon; Rats; Rats, Sprague-Dawley | 1993 |
Updates on attention deficit hyperactivity disorder, child abuse and neglect, and sudden infant death syndrome.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Abuse; Child Abuse, Sexual; Desipramine; Dopamine Uptake Inhibitors; Humans; Infant; Methylphenidate; Prone Position; Propylamines; Risk Factors; Sudden Infant Death | 2003 |
Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine.
Topics: Animals; Atomoxetine Hydrochloride; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Macaca mulatta; Male; Methylphenidate; Propylamines; Reaction Time; Reinforcement, Psychology; Self Administration | 2004 |
Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Cocaine; Desipramine; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Female; Infusion Pumps; Macaca mulatta; Methylphenidate; Propylamines; Reinforcement, Psychology; Self Administration; Substance-Related Disorders | 2005 |
Nonstimulant medications for the treatment of ADHD.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Desipramine; Humans; Propylamines; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors | 2006 |
Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).
Topics: Adrenergic Uptake Inhibitors; Amines; Atomoxetine Hydrochloride; Binding Sites; Cell Line; Chemistry, Pharmaceutical; Desipramine; Drug Design; Humans; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Structure-Activity Relationship | 2008 |
Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Chlorocebus aethiops; Choice Behavior; Desipramine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Male; Memory; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Propylamines; Psychomotor Performance; Rats; Rats, Long-Evans; Reversal Learning; Space Perception | 2009 |
Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Desipramine; Dextroamphetamine; Impulsive Behavior; Male; Methylphenidate; Propylamines; Rats; Rats, Wistar | 2011 |
Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: involvement of α2 adrenergic receptors.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Animals; Astrocytes; Atomoxetine Hydrochloride; Cells, Cultured; Chemokine CCL2; Clonidine; Cyclic AMP; Desipramine; Isoproterenol; Norepinephrine; Propylamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Yohimbine | 2011 |
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Brain; Chlorpromazine; Citalopram; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Magnesium; Male; Membrane Potentials; N-Methylaspartate; Neurons; Neurotransmitter Agents; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2017 |